Daniel Chancellor

Biopharma industry advisor with ~15 years of experience spanning drug discovery, market analysis, competitive intelligence, and strategic consulting. Currently delivering and overseeing thought leadership activities for Citeline and Evaluate, using proprietary, gold-standard datasets to communicate the opportunities and challenges facing the industry today. Regular contributor to Scrip and In Vivo newsletters, external commentator for leading business publications, including the WSJ, Reuters and The Economist, plus a frequent speaker and presenter at partnering conferences across the US, Europe and Japan.